Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.22 USD | +4.65% | +0.87% | +8.93% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 783M |
---|---|---|---|---|---|
Net income 2024 * | -173M | Net income 2025 * | -171M | EV / Sales 2024 * | - |
Net Debt 2024 * | 952K | Net Debt 2025 * | 13.89M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.96
x | P/E ratio 2025 * |
-5.74
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.99% |
Latest transcript on ALX Oncology Holdings Inc.
1 day | +4.65% | ||
1 week | +11.94% | ||
Current month | +45.47% | ||
1 month | +38.16% | ||
3 months | +19.35% | ||
6 months | +133.89% | ||
Current year | +8.93% |
Managers | Title | Age | Since |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 15-03-31 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 20-03-31 |
Peter García
DFI | Director of Finance/CFO | 62 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 22-11-27 |
Corey Goodman
CHM | Chairman | 72 | 15-02-28 |
Jack Nielsen
BRD | Director/Board Member | 60 | 20-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 16.22 | +4.65% | 441,585 |
24-04-23 | 15.5 | +8.92% | 443,830 |
24-04-22 | 14.23 | -8.78% | 287,330 |
24-04-19 | 15.6 | -0.89% | 477,111 |
24-04-18 | 15.74 | -2.11% | 667,313 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 783M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- ALXO Stock